SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001070081-17-000051
Filing Date
2017-01-17
Accepted
2017-01-17 16:35:52
Documents
1
Period of Report
2017-01-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148468893986388.html 4  
1 FORM 4 wf-form4_148468893986388.xml 4 14071
  Complete submission text file 0001070081-17-000051.txt   15554
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Issuer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850 CAMBRIDGE MA 02142
Business Address
Rothera Mark (Reporting) CIK: 0001550424 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35969 | Film No.: 17531101